New York, NYNCT00843375Now EnrollingIRB Ready

Colonic Neoplasms Clinical Trial in New York, NY

Access cutting-edge colonic neoplasms treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by University of Michigan Rogel Cancer Center

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access colonic neoplasms specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related colonic neoplasms treatment provided free

Apply for This New York Location

Check if you qualify for this colonic neoplasms clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Colonic Neoplasms Study in New York

Colon cancer is the second most common cancer in men and women. It is a disease that can be prevented if it is found early. Colonoscopy is still the best screening tool for colon cancer and the polyps that turn into colon cancer. However, due to a variety of factors, including affordability, time, and age, not all patients are able to be screened. Researchers are working on other options for early detection that are as accurate as colonoscopy. The purpose of this study if to determine if stool or blood can be used to detect colon cancers as early or earlier than colonoscopy. The researchers plan to use these samples to learn about specific proteins (also known as biomarkers) that may indicate colon polyps, colon cancer or an increased risk of developing colon cancer. In order to learn more about preventing and detecting colon and rectal cancer, we are collecting samples from subjects with cancer, adenomas, and colonoscopies who may be at risk for polyps.

Sponsor: University of Michigan Rogel Cancer Center

Who Can Participate

Inclusion Criteria

Willing to sign informed consent
Able to physically tolerate removal of up to 60 ml of blood
Adults at least 18 years old
Willing to collect 1-2 stool samples and prepare a Fecal Immunochemical Test (FIT)
Pregnant or nursing women who otherwise meet the eligibility criteria may participate
Subjects with one of the following:
Colorectal adenocarcinoma-not treated and in colon at time of stool collection (CRC bin)
Adenoma-pathologically confirmed adenoma present in colon at time of stool collection (Adenoma Bin)
Higher Risk Non-neoplastic Bin
Subjects with a personal history of adenomas (confirmed by pathology) with none present on qualifying colonoscopy
Subjects with a personal history of CRC (longer than 3 years ago because of

Exclusion Criteria

of cancer within last 3 years) with none present at time of qualifying colonoscopy
Any family history of CRC (1st degree relative)
Current positive screening stool test for blood, for DNA or for both within 12 months with no follow-up intervention.
Average Risk, Non-neoplastic Bin
No history or current finding of any colorectal neoplasia including CRC, adenomas, sessile serrated adenomas and no family history of CRC.
Subjects who had CRC that was successfully treated at least three years ago may be considered eligible for the adenoma bin if their polyps are adenomas and there is no evidence of CRC, or for the higher risk non-neoplastic bin as noted above.
Subjects whose screening colonoscopy shows any of these types of polyps may be included in the non-neoplastic or the higher risk non-neoplastic bin if they meet the other criteria noted above.
Hyperplastic polyps
Benign mucosal polyps
Polypoid granulation tissue
Prolapsed mucosal polyps
Inflammatory polyp
Transitional mucosal polyp
Gangleoneuroma
Hamartomatous polyp Exclusion Criteria:
Cancer patients who have had any surgery, radiation, or chemotherapy for their current colorectal cancer prior to collecting the baseline samples
History of or clinically active Inflammatory Bowel Disease
Known HNPCC or FAP
Inability to provide informed consent.
Other active malignancy within 3 years of enrollment except any of the following:
Squamous cell carcinoma of the skin
Basal cell carcinoma of the skin
Carcinoma in situ of the cervix, Stages Ia or Ib invasive squamous cell carcinoma of the cervix treated by surgery only. (Excluded if had pelvic radiation)
Stage Ia Grade 1 adenocarcinoma of the endometrium treated with surgery
Patients on active chemotherapy or radiation treatment for any purpose
Known HIV or chronic active viral hepatitis
Women who are pregnant
CT colonography (virtual colonoscopy) patients

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT00843375) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Colonic Neoplasms Treatment Options in New York, NY

If you're searching for colonic neoplasms treatment options in New York, NY, this clinical trial (NCT00843375) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colonic neoplasms specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all colonic neoplasms clinical trials near you to find additional studies recruiting in your area.

More Multiple Sclerosis Trials in New York, NY

See all multiple sclerosis clinical trials recruiting in New York — not just this study.

Browse Multiple Sclerosis Trials in New York

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY